Department of Medicine, University of Texas Medical Branch, Galveston, Texas 77555-0764, USA.
J Pain. 2012 Sep;13(9):901-9. doi: 10.1016/j.jpain.2012.06.002.
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder in which the pathophysiological mechanisms of the pain and hypersensitivity are incompletely understood. IBS patients frequently complain of pain in body regions somatotopically distinct from the gut, suggesting involvement of central hyperalgesic mechanisms. We tested the role of tonic peripheral impulse input by using both repetitive thermal stimuli to the leg and repetitive stimuli to the rectum. Changes in thermal/visceral pain sensitivity after nociceptive thermal/visceral repetitive stimulation were determined. A subset of IBS patients showed enhanced rectal/thermal pain sensitivity after repetitive thermal/rectal stimulation, respectively. IBS patients then received 60 mg dextromethorphan and placebo (diphenhydramine) in a randomized, double-blind, crossover trial. The results showed that 1) a subset of IBS patients had increased visceral/cutaneous hypersensitivity following a series of repetitive nociceptive stimuli and that 2) this increased pain sensitivity was blocked by administration of dextromethorphan. This is the first human study indicating that repetitive stimulation enhances a bidirectional mechanism of secondary hyperalgesia due to viscerosomatic facilitation in IBS patients. These unique findings elucidate mechanisms of somatic hypersensitivity in IBS patients and support an etiologic basis for abnormal N-methyl-D-aspartate receptor mechanisms that may be the target of future therapies for IBS.
Repetitive stimulation enhances a bidirectional mechanism of secondary hyperalgesia due to viscerosomatic convergence in IBS patients. The findings elucidate unique mechanisms of somatic/visceral hypersensitivity in a subset of IBS patients and further support an etiologic basis for abnormal N-methyl-D-aspartate receptor mechanisms that may be future targets of therapies for IBS.
肠易激综合征(IBS)是一种常见的胃肠道疾病,其疼痛和超敏反应的病理生理机制尚不完全清楚。IBS 患者常主诉躯体区域疼痛,这些躯体区域与肠道在体感上存在差异,提示中枢性痛觉过敏机制的参与。我们通过腿部重复热刺激和直肠重复刺激来测试紧张性外周冲动输入的作用。分别测定内脏/热痛觉敏感性在痛觉/内脏重复刺激后的变化。IBS 患者中的一部分在重复热/直肠刺激后表现出直肠/热痛觉敏感性增强。随后,IBS 患者在随机、双盲、交叉试验中接受了 60mg 右美沙芬和安慰剂(苯海拉明)。结果显示:1)IBS 患者中存在一系列重复伤害性刺激后内脏/皮肤敏感性增加的亚组;2)这种痛觉敏感性增加可被右美沙芬阻断。这是首例表明重复刺激增强了内脏躯体感觉易化导致的 IBS 患者中二级痛觉过敏的双向机制的人类研究。这些独特的发现阐明了 IBS 患者躯体超敏反应的机制,并支持异常 N-甲基-D-天冬氨酸受体机制作为未来 IBS 治疗靶点的病因基础。
重复刺激增强了内脏躯体感觉会聚导致的 IBS 患者中二级痛觉过敏的双向机制。这些发现阐明了 IBS 患者中躯体/内脏超敏反应的独特机制,并进一步支持异常 N-甲基-D-天冬氨酸受体机制作为未来 IBS 治疗靶点的病因基础。